Cell selection as driving force in lung and colon carcinogenesis

Cancer Research

Volumn 70, Issue 17, 2010, Pages 6797-6803

  Schöllnberger, Helmut ^a,b   Beerenwinkel, Niko ^c   Hoogenveen, Rudolf ^d   Vineis, Paolo ^e,f  

^a UNIVERSITY OF SALZBURG   (Austria)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c ETH ZURICH   (Switzerland)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e ISI FOUNDATION   (Italy)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; CELL SELECTION; CLONOGENESIS; COLON CARCINOGENESIS; DARWINIAN THEORY; EVOLUTION; LUNG CARCINOGENESIS; MUTATION RATE; PRIORITY JOURNAL; THEORETICAL MODEL; BIOLOGICAL MODEL; COLON TUMOR; GENETICS; LUNG TUMOR; PATHOLOGY; STATISTICS;

COLONIC NEOPLASMS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; MODELS, GENETIC; STOCHASTIC PROCESSES;

EID: 77956291154     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-4392     Document Type: Article

References (42)

1. Day NE. Epidemiological data and multistage carcinogenesis. IARC Sci Publ 1984;56:339-57.
2. Day NE, Brown CC. Multistage models and primary prevention of cancer. J Natl Cancer Inst 1980;64:977-89.
3. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1-12.
4. Armitage P, Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer 1957;11:161-9.
5. Gatenby RA, Vincent TL. An evolutionary model of carcinogenesis. Cancer Res 2003;63:6212-20.
6. Beerenwinkel N, Antal T, Dingli D, et al. Genetic progression and the waiting time to cancer. PLoS Comput Biol 2007;3:2239-46. (Pubitemid 350241947)
7. Moolgavkar SH, Venzon D. Two-event models for carcinogenesis: incidence curves for childhood and adult tumors. Math Biosci 1979;47:55-77.
8. Moolgavkar SH, Knudson AG, Jr. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst 1981;66:1037-52.
9. Michor F, Iwasa Y, Nowak MA. Dynamics of cancer progression. Nat Rev Cancer 2004;4:197-205.
10. Vineis P, Schatzkin A, Potter JD. Models of carcinogenesis: an overview. Carcinogenesis 2010 May 11; [Epub ahead of print].
11. Ewens WJ. Mathematical population genetics. New York: Springer; 2004.
12. Heidenreich WF. On the parameters of the clonal expansion model. Radiat Environ Biophys 1996;35:127-29.
13. Chen CW. Armitage-Doll two-stage model: implications and extension. Risk Anal 1993;13:273-9.
14. Rodin SN, Rodin AS. Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol 2005;15:103-12.
15. Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med 1999;5:11-2. (Pubitemid 29050986)
16. Tomlinson IPM, Novelli MR, Bodmer WF. The mutation rate and cancer. Proc Natl Acad Sci U S A 1996;93:14800-3.
17. Sjöblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314:268-74.
18. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318: 1108-13.
19. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-6.
20. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321: 1807-12.
21. Gerstung M, Beerenwinkel N. Waiting time models of cancer progression. Math Popul Stud 2010;17:115-35.
22. Maley CC. Multistage carcinogenesis in Barrett's esophagus. Cancer Lett 2007;245:22-32.
23. Moolgavkar SH, Dewanji A, Venzon DJ. A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor. Risk Anal 1988;8:383-92.
24. Hoogenveen RT, Clewell HJ, Andersen ME, Slob W. An alternative exact solution to the two-stage clonal growth model of cancer. Risk Anal 1999;19:9-14. (Pubitemid 29236980)
25. Luebeck EG, Heidenreich WF, Hazelton WD, et al. Biologically based analysis of the data for the Colorado uranium miners cohort: age, dose and dose-rate effects. Radiat Res 1999;152:339-51.
26. Schöllnberger H, Manuguerra M, Bijwaard H, et al. Analysis of epidemiological cohort data on smoking effects and lung cancer with multistage cancer models. Carcinogenesis 2006;27: 1432-44.
27. Meza R, Jeon J, Moolgavkar SH, Luebeck EG. Age-specific incidence of cancer: phases, transitions, and biological implications. Proc Natl Acad Sci U S A 2008;105:16284-9.
28. Meza R, Hazelton WD, Colditz GA, Moolgavkar SH. Cancer Causes Control 2008;19:317-28.
29. Hazelton WD, Clements MS, Moolgavkar SH. Multistage carcinogenesis and lung cancer mortality in three cohorts. Cancer Epidemiol Biomarkers Prev 2005;14:1171-81.
30. Moolgavkar SH, Luebeck EG, Krewski D, et al. Radon, cigarette smoke, and lung cancer: a re-analysis of the Colorado Plateau uranium miners' data. Epidemiology 1993;4:204-17.
31. Moolgavkar SH, Dewanji A, Luebeck G. Cigarette smoking and lung cancer: reanalysis of the British doctors' data. J Natl Cancer Inst 1989;81:415-20. (Pubitemid 19075063)
32. Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A 2002;99: 15095-100.
33. Moolgavkar SH, Luebeck EG. Multistage carcinogenesis: population- based model for colon cancer. J Natl Cancer Inst 1992;84: 610-18.
34. Park S-C, Simon D, Krug J. The speed of evolution in large asexual populations. J Stat Phys 2010;138:381-410.
35. Moolgavkar SH. Carcinogenesis models: An overview. In: Glass WA, Varma MN, editors. Physical and chemical mechanisms in molecular radiation biology. New York: Plenum Press; 1991, p. 387-99.
36. Herrero-Jimenez P, Tomita-Mitchell A, Furth EE, et al. Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States. Mutat Res 2000;447:73-116.
37. Tannenbaum A. The dependence of the genesis of induced skin tumors on the caloric intake during different stages of carcinogenesis. Cancer Res 1944;4:673-7.
38. Rubin H. Selected cell and selective microenvironment in neoplastic development. Cancer Res 2001;61:799-807.
39. Rubin H. Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype. Proc Natl Acad Sci U S A 2008;105:6215-21. (Pubitemid 351758326)
40. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci U S A 2003;100:776-81.
41. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.
42. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323-9.